Skip to main content
Top
Published in: Cancer Cell International 1/2014

Open Access 01-12-2014 | Primary research

Glucose restriction decreases telomerase activity and enhances its inhibitor response on breast cancer cells: possible extra-telomerase role of BIBR 1532

Authors: Layal Wardi, Nada Alaaeddine, Issam Raad, Riad Sarkis, Rim Serhal, Charbel Khalil, George Hilal

Published in: Cancer Cell International | Issue 1/2014

Login to get access

Abstract

Background

Considerable progress has been made to understand the association between lifestyle and diet in cancer initiation and promotion. Because excessive glucose consumption is a key metabolic hallmark of cancer cells, glucose restriction (GR) decreases the proliferation, and promotes the differentiation and transformation of cancer cells to quiescent cells. The immortality of cancerous cells is largely assured by telomerase, which is an interesting target for inhibition by BIBR 1532. In this study, we investigated the effect of GR on telomerase activity and on the efficacy of its inhibition by BIBR 1532.

Methods

Breast cancer MDA-MB 231 and MCF-7 cells were cultured in DMEM (Dulbecco’s modified eagle’s media) with 0, 1 or 4.5 g/l of glucose. The telomerase activity was measured via quantitative Real-Time PCR, and the two telomerase subunits were semi-quantified by RT-PCR. Proliferation test and mitochondrial metabolism were assessed via tetrazolium salt reduction and cell counts; apoptosis was assessed via caspase-3 quantification and flow cytometry.

Results

A decrease in the telomerase activity of more than 75% was associated with a significant reduction in the mRNA expression of its catalytic subunit hTERT (Reverse Transcriptase) and a decrease in the mitochondrial metabolism by more than 80% under restricted glucose conditions. In addition, GR increased the effect of BIBR 1532. Glucose deprivation induces apoptosis via BIBR 1532-mediated telomerase inhibition in triple negative breast cancer cells, as assessed by caspase-3 measurements and Annexin analysis.

Conclusions

Taken together, our results suggest that the effect of BIBR 1532 is potentiated by GR to induce triple negative breast cancer cell death.
Appendix
Available only for authorised users
Literature
1.
go back to reference Osborne TB, Mendel LB, Ferry EL: The effect of retardation of growth upon the breeding and duration of life of rats. Science. 1917, 45: 294-295. 10.1126/science.45.1160.294.CrossRefPubMed Osborne TB, Mendel LB, Ferry EL: The effect of retardation of growth upon the breeding and duration of life of rats. Science. 1917, 45: 294-295. 10.1126/science.45.1160.294.CrossRefPubMed
2.
go back to reference Martin B, Golden E, Egan JM, Mattson MP, Maudsley S: Reduced energy intake: the secret to a long and healthy life?. IBS J Sci. 2007, 2: 35-39.PubMedCentralPubMed Martin B, Golden E, Egan JM, Mattson MP, Maudsley S: Reduced energy intake: the secret to a long and healthy life?. IBS J Sci. 2007, 2: 35-39.PubMedCentralPubMed
3.
go back to reference Longo VD, Fontana L: Calorie restriction and cancer prevention: metabolic and molecular mechanisms. Trends Pharmacol Sci. 2010, 31: 89-98. 10.1016/j.tips.2009.11.004.CrossRefPubMedCentralPubMed Longo VD, Fontana L: Calorie restriction and cancer prevention: metabolic and molecular mechanisms. Trends Pharmacol Sci. 2010, 31: 89-98. 10.1016/j.tips.2009.11.004.CrossRefPubMedCentralPubMed
4.
go back to reference Colman RJ, Anderson RM, Johnson SC, Kastman EK, Kosmatka KJ, Beasley TM, Allison DB, Cruzen C, Simmons HA, Kemnitz JW, Weindruch R: Caloric restriction delays disease onset and mortality in rhesus monkeys. Science. 2009, 325: 201-204. 10.1126/science.1173635.CrossRefPubMedCentralPubMed Colman RJ, Anderson RM, Johnson SC, Kastman EK, Kosmatka KJ, Beasley TM, Allison DB, Cruzen C, Simmons HA, Kemnitz JW, Weindruch R: Caloric restriction delays disease onset and mortality in rhesus monkeys. Science. 2009, 325: 201-204. 10.1126/science.1173635.CrossRefPubMedCentralPubMed
5.
go back to reference Fontana L, Klein S: Aging, adiposity, and calorie restriction. JAMA J Am Med Assoc. 2007, 297: 986-994. 10.1001/jama.297.9.986.CrossRef Fontana L, Klein S: Aging, adiposity, and calorie restriction. JAMA J Am Med Assoc. 2007, 297: 986-994. 10.1001/jama.297.9.986.CrossRef
6.
go back to reference Hanahan D, Weinberg RA: Hallmarks of cancer: the next generation. Cell. 2011, 144: 646-674. 10.1016/j.cell.2011.02.013.CrossRefPubMed Hanahan D, Weinberg RA: Hallmarks of cancer: the next generation. Cell. 2011, 144: 646-674. 10.1016/j.cell.2011.02.013.CrossRefPubMed
7.
go back to reference Kolonel LN, Altshuler D, Henderson BE: The multiethnic cohort study: exploring genes, lifestyle and cancer risk. Nat Rev Cancer. 2004, 4: 519-527. 10.1038/nrc1389.CrossRefPubMed Kolonel LN, Altshuler D, Henderson BE: The multiethnic cohort study: exploring genes, lifestyle and cancer risk. Nat Rev Cancer. 2004, 4: 519-527. 10.1038/nrc1389.CrossRefPubMed
8.
go back to reference Baade PD, Youlden DR, Krnjacki LJ: International epidemiology of prostate cancer: geographical distribution and secular trends. Mol Nutr Food Res. 2009, 53: 171-184. 10.1002/mnfr.200700511.CrossRefPubMed Baade PD, Youlden DR, Krnjacki LJ: International epidemiology of prostate cancer: geographical distribution and secular trends. Mol Nutr Food Res. 2009, 53: 171-184. 10.1002/mnfr.200700511.CrossRefPubMed
9.
go back to reference Safdie FM, Dorff T, Quinn D, Fontana L, Wei M, Lee C, Cohen P, Longo VD: Fasting and cancer treatment in humans: a case series report. Aging. 2009, 1: 988-1007.PubMedCentralPubMed Safdie FM, Dorff T, Quinn D, Fontana L, Wei M, Lee C, Cohen P, Longo VD: Fasting and cancer treatment in humans: a case series report. Aging. 2009, 1: 988-1007.PubMedCentralPubMed
10.
go back to reference Kim NW, Piatyszek MA, Prowse KR, Harley CB, West MD, Ho PL, Coviello GM, Wright WE, Weinrich SL, Shay JW: Specific association of human telomerase activity with immortal cells and cancer. Science. 1994, 266: 2011-2015. 10.1126/science.7605428.CrossRefPubMed Kim NW, Piatyszek MA, Prowse KR, Harley CB, West MD, Ho PL, Coviello GM, Wright WE, Weinrich SL, Shay JW: Specific association of human telomerase activity with immortal cells and cancer. Science. 1994, 266: 2011-2015. 10.1126/science.7605428.CrossRefPubMed
11.
go back to reference Janknecht R: On the road to immortality: hTERT upregulation in cancer cells. FEBS Lett. 2004, 564: 9-13. 10.1016/S0014-5793(04)00356-4.CrossRefPubMed Janknecht R: On the road to immortality: hTERT upregulation in cancer cells. FEBS Lett. 2004, 564: 9-13. 10.1016/S0014-5793(04)00356-4.CrossRefPubMed
12.
go back to reference Autexier C, Lue NF: The structure and function of telomerase reverse transcriptase. Annu Rev Biochem. 2006, 75: 493-517. 10.1146/annurev.biochem.75.103004.142412.CrossRefPubMed Autexier C, Lue NF: The structure and function of telomerase reverse transcriptase. Annu Rev Biochem. 2006, 75: 493-517. 10.1146/annurev.biochem.75.103004.142412.CrossRefPubMed
13.
go back to reference Shay JW, Wright WE: Senescence and immortalization: role of telomeres and telomerase. Carcinogenesis. 2005, 26: 867-874.CrossRefPubMed Shay JW, Wright WE: Senescence and immortalization: role of telomeres and telomerase. Carcinogenesis. 2005, 26: 867-874.CrossRefPubMed
14.
go back to reference Hursting SD, Lavigne JA, Berrigan D, Perkins SN, Barrett JC: Calorie restriction, aging, and cancer prevention: mechanisms of action and applicability to humans. Annu Rev Med. 2003, 54: 131-152. 10.1146/annurev.med.54.101601.152156.CrossRefPubMed Hursting SD, Lavigne JA, Berrigan D, Perkins SN, Barrett JC: Calorie restriction, aging, and cancer prevention: mechanisms of action and applicability to humans. Annu Rev Med. 2003, 54: 131-152. 10.1146/annurev.med.54.101601.152156.CrossRefPubMed
15.
go back to reference Grizzi F, Di Ieva A, Russo C, Frezza EE, Cobos E, Muzzio PC, Chiriva-Internati M: Cancer initiation and progression: an unsimplifiable complexity. Theor Biol Med Model. 2006, 3: 37-10.1186/1742-4682-3-37.CrossRefPubMedCentralPubMed Grizzi F, Di Ieva A, Russo C, Frezza EE, Cobos E, Muzzio PC, Chiriva-Internati M: Cancer initiation and progression: an unsimplifiable complexity. Theor Biol Med Model. 2006, 3: 37-10.1186/1742-4682-3-37.CrossRefPubMedCentralPubMed
16.
go back to reference DeBerardinis RJ, Lum JJ, Hatzivassiliou G, Thompson CB: The biology of cancer: metabolic reprogramming fuels cell growth and proliferation. Cell Metab. 2008, 7: 11-20. 10.1016/j.cmet.2007.10.002.CrossRefPubMed DeBerardinis RJ, Lum JJ, Hatzivassiliou G, Thompson CB: The biology of cancer: metabolic reprogramming fuels cell growth and proliferation. Cell Metab. 2008, 7: 11-20. 10.1016/j.cmet.2007.10.002.CrossRefPubMed
17.
go back to reference Hsu PP, Sabatini DM: Cancer cell metabolism: warburg and beyond. Cell. 2008, 134: 703-707. 10.1016/j.cell.2008.08.021.CrossRefPubMed Hsu PP, Sabatini DM: Cancer cell metabolism: warburg and beyond. Cell. 2008, 134: 703-707. 10.1016/j.cell.2008.08.021.CrossRefPubMed
18.
go back to reference Warburg O: On respiratory impairment in cancer cells. Science. 1956, 124: 269-270.PubMed Warburg O: On respiratory impairment in cancer cells. Science. 1956, 124: 269-270.PubMed
19.
go back to reference Hammerman PS, Fox CJ, Thompson CB: Beginnings of a signal-transduction pathway for bioenergetic control of cell survival. Trends Biochem Sci. 2004, 29: 586-592. 10.1016/j.tibs.2004.09.008.CrossRefPubMed Hammerman PS, Fox CJ, Thompson CB: Beginnings of a signal-transduction pathway for bioenergetic control of cell survival. Trends Biochem Sci. 2004, 29: 586-592. 10.1016/j.tibs.2004.09.008.CrossRefPubMed
20.
go back to reference Kyo S, Takakura M, Taira T, Kanaya T, Itoh H, Yutsudo M, Ariga H, Inoue M: Sp1 cooperates with c-Myc to activate transcription of the human telomerase reverse transcriptase gene (hTERT). Nucleic Acids Res. 2000, 28: 669-677. 10.1093/nar/28.3.669.CrossRefPubMedCentralPubMed Kyo S, Takakura M, Taira T, Kanaya T, Itoh H, Yutsudo M, Ariga H, Inoue M: Sp1 cooperates with c-Myc to activate transcription of the human telomerase reverse transcriptase gene (hTERT). Nucleic Acids Res. 2000, 28: 669-677. 10.1093/nar/28.3.669.CrossRefPubMedCentralPubMed
21.
go back to reference Klement RJ, Kämmerer U: Is there a role for carbohydrate restriction in the treatment and prevention of cancer?. Nutr Metab. 2011, 8: 75-10.1186/1743-7075-8-75.CrossRef Klement RJ, Kämmerer U: Is there a role for carbohydrate restriction in the treatment and prevention of cancer?. Nutr Metab. 2011, 8: 75-10.1186/1743-7075-8-75.CrossRef
22.
go back to reference Jiang W, Zhu Z, Thompson HJ: Dietary energy restriction modulates the activity of AMP-activated protein kinase, Akt, and mammalian target of rapamycin in mammary carcinomas, mammary gland, and liver. Cancer Res. 2008, 68: 5492-5499. 10.1158/0008-5472.CAN-07-6721.CrossRefPubMedCentralPubMed Jiang W, Zhu Z, Thompson HJ: Dietary energy restriction modulates the activity of AMP-activated protein kinase, Akt, and mammalian target of rapamycin in mammary carcinomas, mammary gland, and liver. Cancer Res. 2008, 68: 5492-5499. 10.1158/0008-5472.CAN-07-6721.CrossRefPubMedCentralPubMed
23.
go back to reference Pollak M: Insulin and insulin-like growth factor signalling in neoplasia. Nat Rev Cancer. 2008, 8: 915-928. 10.1038/nrc2536.CrossRefPubMed Pollak M: Insulin and insulin-like growth factor signalling in neoplasia. Nat Rev Cancer. 2008, 8: 915-928. 10.1038/nrc2536.CrossRefPubMed
24.
go back to reference Seyfried TN, Shelton LM: Cancer as a metabolic disease. Nutr Metab. 2010, 7: 7-10.1186/1743-7075-7-7.CrossRef Seyfried TN, Shelton LM: Cancer as a metabolic disease. Nutr Metab. 2010, 7: 7-10.1186/1743-7075-7-7.CrossRef
25.
go back to reference Li Y, Liu L, Tollefsbol TO: Glucose restriction can extend normal cell lifespan and impair precancerous cell growth through epigenetic control of hTERT and p16 expression. FASEB J Off Publ Fed Am Soc Exp Biol. 2010, 24: 1442-1453. Li Y, Liu L, Tollefsbol TO: Glucose restriction can extend normal cell lifespan and impair precancerous cell growth through epigenetic control of hTERT and p16 expression. FASEB J Off Publ Fed Am Soc Exp Biol. 2010, 24: 1442-1453.
26.
go back to reference Pascolo E, Wenz C, Lingner J, Hauel N, Priepke H, Kauffmann I, Garin-Chesa P, Rettig WJ, Damm K, Schnapp A: Mechanism of human telomerase inhibition by BIBR1532, a synthetic, non-nucleosidic drug candidate. J Biol Chem. 2002, 277: 15566-15572. 10.1074/jbc.M201266200.CrossRefPubMed Pascolo E, Wenz C, Lingner J, Hauel N, Priepke H, Kauffmann I, Garin-Chesa P, Rettig WJ, Damm K, Schnapp A: Mechanism of human telomerase inhibition by BIBR1532, a synthetic, non-nucleosidic drug candidate. J Biol Chem. 2002, 277: 15566-15572. 10.1074/jbc.M201266200.CrossRefPubMed
27.
go back to reference Janjic D, Wollheim CB: Islet cell metabolism is reflected by the MTT (tetrazolium) colorimetric assay. Diabetologia. 1992, 35: 482-485. 10.1007/BF02342448.CrossRefPubMed Janjic D, Wollheim CB: Islet cell metabolism is reflected by the MTT (tetrazolium) colorimetric assay. Diabetologia. 1992, 35: 482-485. 10.1007/BF02342448.CrossRefPubMed
28.
go back to reference Berridge MV, Tan AS: Characterization of the cellular reduction of 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT): subcellular localization, substrate dependence, and involvement of mitochondrial electron transport in MTT reduction. Arch Biochem Biophys. 1993, 303: 474-482. 10.1006/abbi.1993.1311.CrossRefPubMed Berridge MV, Tan AS: Characterization of the cellular reduction of 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT): subcellular localization, substrate dependence, and involvement of mitochondrial electron transport in MTT reduction. Arch Biochem Biophys. 1993, 303: 474-482. 10.1006/abbi.1993.1311.CrossRefPubMed
29.
go back to reference Pantic M, Zimmermann S, El Daly H, Opitz OG, Popp S, Boukamp P, Martens UM: Telomere dysfunction and loss of p53 cooperate in defective mitotic segregation of chromosomes in cancer cells. Oncogene. 2006, 25: 4413-4420. 10.1038/sj.onc.1209486.CrossRefPubMed Pantic M, Zimmermann S, El Daly H, Opitz OG, Popp S, Boukamp P, Martens UM: Telomere dysfunction and loss of p53 cooperate in defective mitotic segregation of chromosomes in cancer cells. Oncogene. 2006, 25: 4413-4420. 10.1038/sj.onc.1209486.CrossRefPubMed
30.
go back to reference Pantic M, Zimmermann S, Waller CF, Martens UM: The level of telomere dysfunction determines the efficacy of telomerase-based therapeutics in a lung cancer cell line. Int J Oncol. 2005, 26: 1227-1232.PubMed Pantic M, Zimmermann S, Waller CF, Martens UM: The level of telomere dysfunction determines the efficacy of telomerase-based therapeutics in a lung cancer cell line. Int J Oncol. 2005, 26: 1227-1232.PubMed
31.
go back to reference Nicolucci A: Epidemiological aspects of neoplasms in diabetes. Acta Diabetol. 2010, 47: 87-95. 10.1007/s00592-010-0187-3.CrossRefPubMed Nicolucci A: Epidemiological aspects of neoplasms in diabetes. Acta Diabetol. 2010, 47: 87-95. 10.1007/s00592-010-0187-3.CrossRefPubMed
32.
go back to reference Sauer LA, Dauchy RT: Stimulation of tumor growth in adult rats in vivo during acute streptozotocin-induced diabetes. Cancer Res. 1987, 47: 1756-1761.PubMed Sauer LA, Dauchy RT: Stimulation of tumor growth in adult rats in vivo during acute streptozotocin-induced diabetes. Cancer Res. 1987, 47: 1756-1761.PubMed
33.
go back to reference Brookes PS: Mitochondrial proton leak and superoxide generation: an hypothesis. Biochem Soc Trans. 1998, 26: S331-CrossRefPubMed Brookes PS: Mitochondrial proton leak and superoxide generation: an hypothesis. Biochem Soc Trans. 1998, 26: S331-CrossRefPubMed
34.
go back to reference Oyedotun KS, Lemire BD: The quaternary structure of the Saccharomyces cerevisiae succinate dehydrogenase. Homology modeling, cofactor docking, and molecular dynamics simulation studies. J Biol Chem. 2004, 279: 9424-9431. 10.1074/jbc.M311876200.CrossRefPubMed Oyedotun KS, Lemire BD: The quaternary structure of the Saccharomyces cerevisiae succinate dehydrogenase. Homology modeling, cofactor docking, and molecular dynamics simulation studies. J Biol Chem. 2004, 279: 9424-9431. 10.1074/jbc.M311876200.CrossRefPubMed
35.
go back to reference Apel K, Hirt H: Reactive oxygen species: metabolism, oxidative stress, and signal transduction. Annu Rev Plant Biol. 2004, 55: 373-399. 10.1146/annurev.arplant.55.031903.141701.CrossRefPubMed Apel K, Hirt H: Reactive oxygen species: metabolism, oxidative stress, and signal transduction. Annu Rev Plant Biol. 2004, 55: 373-399. 10.1146/annurev.arplant.55.031903.141701.CrossRefPubMed
36.
go back to reference Anastasiou D, Poulogiannis G, Asara JM, Boxer MB, Jiang J, Shen M, Bellinger G, Sasaki AT, Locasale JW, Auld DS, Thomas CJ, Vander Heiden MG, Cantley LC: Inhibition of pyruvate kinase M2 by reactive oxygen species contributes to cellular antioxidant responses. Science. 2011, 334: 1278-1283. 10.1126/science.1211485.CrossRefPubMedCentralPubMed Anastasiou D, Poulogiannis G, Asara JM, Boxer MB, Jiang J, Shen M, Bellinger G, Sasaki AT, Locasale JW, Auld DS, Thomas CJ, Vander Heiden MG, Cantley LC: Inhibition of pyruvate kinase M2 by reactive oxygen species contributes to cellular antioxidant responses. Science. 2011, 334: 1278-1283. 10.1126/science.1211485.CrossRefPubMedCentralPubMed
37.
go back to reference Shay JW, Wright WE: Telomerase therapeutics for cancer: challenges and new directions. Nat Rev Drug Discov. 2006, 5: 577-584. 10.1038/nrd2081.CrossRefPubMed Shay JW, Wright WE: Telomerase therapeutics for cancer: challenges and new directions. Nat Rev Drug Discov. 2006, 5: 577-584. 10.1038/nrd2081.CrossRefPubMed
38.
go back to reference Zhou C, Steplowski TA, Dickens HK, Malloy KM, Gehrig PA, Boggess JF, Bae-Jump VL: Estrogen induction of telomerase activity through regulation of the mitogen-activated protein kinase (MAPK) dependent pathway in human endometrial cancer cells. PLoS One. 2013, 8: e55730-10.1371/journal.pone.0055730.CrossRefPubMedCentralPubMed Zhou C, Steplowski TA, Dickens HK, Malloy KM, Gehrig PA, Boggess JF, Bae-Jump VL: Estrogen induction of telomerase activity through regulation of the mitogen-activated protein kinase (MAPK) dependent pathway in human endometrial cancer cells. PLoS One. 2013, 8: e55730-10.1371/journal.pone.0055730.CrossRefPubMedCentralPubMed
Metadata
Title
Glucose restriction decreases telomerase activity and enhances its inhibitor response on breast cancer cells: possible extra-telomerase role of BIBR 1532
Authors
Layal Wardi
Nada Alaaeddine
Issam Raad
Riad Sarkis
Rim Serhal
Charbel Khalil
George Hilal
Publication date
01-12-2014
Publisher
BioMed Central
Published in
Cancer Cell International / Issue 1/2014
Electronic ISSN: 1475-2867
DOI
https://doi.org/10.1186/1475-2867-14-60

Other articles of this Issue 1/2014

Cancer Cell International 1/2014 Go to the issue
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine